TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

89.98

+3.00 (3.45%)

At close: Sep 4, 2026, 4:00 PM EDT

89.88

-0.10 (-0.11%)

After-hours: Sep 4, 2026, 7:51 PM EDT

TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	668.47	605.49	441.54	241.62	93.46	30.26
Revenue Growth	25.82%	37.13%	82.74%	158.53%	208.83%	18.03%
Cost of Revenue	276.12	242.69	179.46	87.53	28.19	9.1
Gross Profit	392.35	362.81	262.08	154.09	65.27	21.16
Selling, General & Admin	218.27	185.17	168.62	119.55	69.9	38.28
Research & Development	92.47	69.06	55.97	36.06	26.81	22.3
Operating Expenses	310.74	254.22	224.59	155.61	96.71	60.59
Operating Income	81.61	108.58	37.5	-1.52	-31.44	-39.43
Interest Expense	-21.24	-13.78	-14.41	-10.79	-3.73	-3.87
Interest & Investment Income	12.3	11.4	13.4	-	-	-
Currency Exchange Gain (Loss)	-2.7	-1	0.7	-	-	-1
Other Non Operating Income (Expenses)	2.59	2.32	-1.41	12.85	-0.43	0.12
EBT Excluding Unusual Items	72.55	107.52	35.78	0.54	-35.59	-44.18
Other Unusual Items	-	-	-	-	-0.58	-
Pretax Income	72.55	107.52	35.78	-26.67	-36.17	-44.18
Income Tax Expense	-79.15	-82.77	0.32	-1.64	0.07	0.04
Net Income	151.7	190.29	35.46	-25.03	-36.23	-44.22
Net Income to Common	151.7	190.29	35.46	-25.03	-36.23	-44.22
Net Income Growth	111.69%	436.58%	-	-	-	-
Shares Outstanding (Basic)	34	34	33	33	30	28
Shares Outstanding (Diluted)	38	41	35	33	30	28
Shares Change	1.53%	15.12%	8.30%	10.02%	7.02%	11.80%
EPS (Basic)	4.42	5.60	1.07	-0.77	-1.23	-1.60
EPS (Diluted)	4.01	4.87	1.01	-0.77	-1.23	-1.60
EPS Growth	98.94%	382.53%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	79.04	133.59	-80.94	-164.88	-57.72	-32.38
Free Cash Flow Per Share	2.06	3.29	-2.30	-5.07	-1.95	-1.17
Gross Margin	58.69%	59.92%	59.36%	63.77%	69.84%	69.92%
Operating Margin	12.21%	17.93%	8.49%	-0.63%	-33.64%	-130.29%
Profit Margin	22.69%	31.43%	8.03%	-10.36%	-38.77%	-146.11%
Free Cash Flow Margin	11.82%	22.06%	-18.33%	-68.24%	-61.76%	-107.01%
EBITDA	115.63	134.47	57.25	6.66	-27.96	-37.61
EBITDA Margin	17.30%	22.21%	12.97%	2.76%	-29.92%	-124.28%
D&A For EBITDA	34.02	25.89	19.76	8.18	3.48	1.82
EBIT	81.61	108.58	37.5	-1.52	-31.44	-39.43
EBIT Margin	12.21%	17.93%	8.49%	-0.63%	-33.64%	-130.29%
Effective Tax Rate	-	-	0.88%	-	-	-
Revenue as Reported	668.47	605.49	441.54	241.62	93.46	30.26

SEC Filings: 10-K · 10-Q